Researchers evaluated the cost-effectiveness ratio of using the 2000-GEP test to identify a primary tumor after clinical and pathological diagnostic evaluations failed.
A report by the National Academies of Sciences, Engineering, and Medicine is calling for the creation of a rapid learning system that would integrate research on the use of biomarker tests and their associated treatments.
Doctors from the University of Wisconsin (Milwaukee, WI) suggest that precision medicine and epigenetics are two emerging fields that could alter the way in which hypertension is treated.
Doctors from Brigham and Women’s Hospital (Boston, MA) have proposed that limiting the overuse of costly resources through predictive analytics could help to reduce rising health care costs for high-risk patient groups.
Infliximab may be slightly better than cyclosporine for treating patients with steroid-refractory ulcerative colitis (UC).
During a session at the ASH meeting, presenters reported on research revealing how some genetic variants are associated with disease severity and treatment-related complications in children with blood diseases